ABSI

Morgan Stanley Initiates Coverage of Absci (ABSI) with Overweight Recommendation

Fintel reports that on July 3, 2024, Morgan Stanley initiated coverage of Absci (NasdaqGS:ABSI) with a Overweight recommendation.

Analyst Price Forecast Suggests 175.85% Upside

As of June 12, 2024, the average one-year price target for Absci is $8.77/share. The forecasts range from a low of $6.06 to a high of $13.65. The average price target represents an increase of 175.85% from its latest reported closing price of $3.18 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Absci is 31MM, an increase of 483.26%. The projected annual non-GAAP EPS is -0.92.

What is the Fund Sentiment?

There are 159 funds or institutions reporting positions in Absci. This is an increase of 51 owner(s) or 47.22% in the last quarter. Average portfolio weight of all funds dedicated to ABSI is 0.08%, an increase of 83.65%. Total shares owned by institutions increased in the last three months by 96.78% to 71,235K shares. ABSI / Absci Corporation Put/Call Ratios The put/call ratio of ABSI is 0.27, indicating a bullish outlook.

What are Other Shareholders Doing?

ABSI / Absci Corporation Shares Held by Institutions

Redmile Group holds 8,253K shares representing 7.30% ownership of the company. In its prior filing, the firm reported owning 8,031K shares , representing an increase of 2.69%. The firm increased its portfolio allocation in ABSI by 42.62% over the last quarter.

Fred Alger Management holds 7,408K shares representing 6.55% ownership of the company.

AOFAX - Alger Small Cap Focus Fund holds 5,807K shares representing 5.13% ownership of the company.

FDGRX - Fidelity Growth Company Fund holds 4,191K shares representing 3.71% ownership of the company. In its prior filing, the firm reported owning 3,949K shares , representing an increase of 5.76%. The firm increased its portfolio allocation in ABSI by 180.02% over the last quarter.

ARKG - ARK Genomic Revolution ETF holds 3,278K shares representing 2.90% ownership of the company. In its prior filing, the firm reported owning 431K shares , representing an increase of 86.85%. The firm increased its portfolio allocation in ABSI by 1,046.04% over the last quarter.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.